Trial · NCT05093478
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Runny Nose as Measured by the Visual Analog Scale (VAS) at Baseline | baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Runny Nose as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | 4 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Runny Nose as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | 12 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Symptoms of Congestion as Measured by the Visual Analog Scale (VAS) at Baseline | baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Symptoms of Congestion as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | 4 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Symptoms of Congestion as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | 12 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Itching as Measured by the Visual Analog Scale (VAS at Baseline | baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Itching as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | 4 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Itching as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | 12 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Sneezing as Measured by the Visual Analog Scale (VAS) at Baseline | baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Sneezing as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | 4 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Nasal Sneezing as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | 12 weeks post treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. |
| Primary | Change in Maximum Optical Density Determined Via Optical Rhinometry | baseline, immediately post first treatment on Day 1 | Optical rhinometry provides continuous measurement of blood flow in nasal vessels (via optical density measurements), which serves as an indirect assessment of nasal congestion. A greater decrease in optical density (OD) from baseline indicates less nasal blood flow and decreased congestion relative to baseline. |
| Primary | Total Nasal Symptom Score as Measured by the Visual Analog Scale (VAS) at Baseline | baseline | Total Nasal Symptom score is measured as the sum of four symptom scores for runny nose, nasal symptoms of congestion, nasal itching and sneezing. Each symptom is scored from 0-10, with 0 being not a problem and 10 being unbearable. The Total nasal symptom score ranges from 0 - 40, the lower the score the better the outcome. |
| Primary | Total Nasal Symptom Score as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | 4 weeks post treatment | Total Nasal Symptom score is measured as the sum of four symptom scores for runny nose, nasal symptoms of congestion, nasal itching and sneezing. Each symptom is scored from 0-10, with 0 being not a problem and 10 being unbearable. The Total nasal symptom score ranges from 0 - 40, the lower the score the better the outcome. |
| Primary | Total Nasal Symptom Score as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | 12 weeks post treatment | Total Nasal Symptom score is measured as the sum of four symptom scores for runny nose, nasal symptoms of congestion, nasal itching and sneezing. Each symptom is scored from 0-10, with 0 being not a problem and 10 being unbearable. The Total nasal symptom score ranges from 0 - 40, the lower the score the better the outcome. |
| Primary | Maximum Optical Density Determined Via Optical Rhinometry | 12 weeks post treatment | |
| Secondary | Change in Local Immunoglobulin E (IgE) Level | baseline, 12 weeks post treatment | The IgE levels will be obtained from the brush biopsy of the inferior turbinates. Change from baseline in local Immunoglobulin E (IgE) level after 12 weeks post treatment. Data reported is the 12 weeks post treatment value minus the baseline value. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05093478/registered